Chapter 90 - Nonatherosclerotic carotid artery disease Flashcards
Rate of carotid stenosis after radiotherapy
25% (16-55)
Rate of restenosis after CEA if radiation done before
6%
Rate of CVA after neck radiation 15 year rate
2.6% vs 0.29% of control 15 year = 12%
Pathophysiology of radiation carotid stenosis
1) endothelial cell and vasa vasorum swell, vacuolization, vesicle formation 2) platelet aggregation and fibrin 3) obstructed lumen in vasa vasorum 4) focal necrosis and fibrosis of media 5) periadventitial fibrosis 6) NO and prostacyclin-mediated endothelium-dependent relaxation impaired 7) long term effect due to sustained activation of TNF kappaB
Difference between radiation plaque and atherosclerotic plaque
1) Radiation more stable 2) less macrophage infiltrate 3) smaller lipid core 4) lesion in CCA and distal ICA
Carotid artery intima-media thickness (CIMT) seen after radiation doses greater than
35 Gy
Factors favoring different carotid treatment modalities
TABLE 90.1

Pec major myocutaneous flap for carotid
1) elliptical skin and soft tissue flap created 2) attachment of pec major divided from anterior chest wall, sternum and clavicle 3) rotate 180 onto thoracoacromial pedicle 4) advance through subcutaneous tunnel to incision in neck
Metaanalysis on radiation carotid 30 d mortality, stroke for symp and asymp for CAS and CEA
SYMPTOMATIC 30d mortality 2.6% CEA 5.1% CAS 30d stroke and death 2.7% CEA vs 5.1% CAS ASYMPTOMATIC 30d mortality 0% CEA 1.4% CAS stroke and death 1.1% CEA 2.3% CAS
Permanent nerve palsy in CEA after radiation
0.6%
Restenosis after radiation carotid treatment
CAS 18% CEA 10%
Restenosis after regular carotid disease treatment
CAS 2-31% CEA 3-12% over 2-5 years
Restenosis > 70% 5 year risk of CVA
23%
Risk of restenosis
1) age 2) female 3) head and neck cancer 4) diabetes 5) smoking 6) dyslipidemia 7) residual stenosis after stent 8) larger number of stents
Restenosis after CEA primary vs patch use
5x more if primary
Trials that looked at restenosis between CEA anc CAS
TABLE 90.3

Proposed duplex criteria for in-stent carotid stenosis
TABLE 90.4 no consensus

Threshold to treat restenosis
> 50% if symptomatic and good risk patient > 80% if asymptomatic
Fokkema meta analysis on CEA to CAS after restenosis CEA
1) 1132 patients 2) CEA younger, more symptomatic and more smokers 3) CAS more HTN, renal failure and antiplatelets 4) no difference in outcome of stroke, death or combined 2.7 vs 2.3% 5) no difference between symp and asymp 6) CN injury 5.5%, bleed 2.7% and wound infection 0.2% higher in CEA 7) access complication 1.9% CAS 8) tech failure CAS 1.3%
Tu meta analysis on CEA vs CAS after restenosis CEA
1) 4399 patients 2) no difference in post-op stroke 3) DN injury 6%; 80% resolve in 3 months 4) restenosis at 5 years 4.4% vs 13.5% of CAS